PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
104.88%
Net income growth under 50% of VET's 315.24%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-33.37%
Negative yoy D&A while VET is 16.88%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
288.62%
Some yoy growth while VET is negative at -55.45%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-394.78%
Both reduce yoy usage, with VET at -186.88%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-394.78%
Negative yoy usage while VET is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
107.01%
Some yoy increase while VET is negative at -71.29%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-44.41%
Both yoy CFO lines are negative, with VET at -21.28%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-13.25%
Negative yoy CapEx while VET is 54.25%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
53.45%
Acquisition growth of 53.45% while VET is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
185.41%
We have some outflow growth while VET is negative at -244.67%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
1873.49%
We have mild expansions while VET is negative at -14.52%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
42.03%
Debt repayment growth of 42.03% while VET is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.